Myocarditis.
Cooper LT Jr.
N Engl J Med. 2009 Apr 9;360(15):1526-38. doi: 10.1056/NEJMra0800028.
Myocarditis in systemic immune-mediated diseases: Prevalence, characteristics and prognosis. A systematic review.
Cheng CY, Baritussio A, Giordani AS, Iliceto S, Marcolongo R, Caforio ALP.
Autoimmun Rev. 2022 Apr;21(4):103037. doi: 10.1016/j.autrev.2022.103037. Epub 2022 Jan 5.
Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis.
Lehtonen J, Uusitalo V, Pöyhönen P, Mäyränpää MI, Kupari M.
Eur Heart J. 2023 May 1;44(17):1495-1510. doi: 10.1093/eurheartj/ehad067.
Cardiac sarcoidosis.
Sohn DW, Park JB.
Heart. 2023 Jul 12;109(15):1132-1138. doi: 10.1136/heartjnl-2022-321379.
Transcriptional and Immune Landscape of Cardiac Sarcoidosis.
Liu J, Ma P, Lai L, Villanueva A, Koenig A, Bean GR, Bowles DE, Glass C, Watson M, Lavine KJ, Lin CY.
Circ Res. 2022 Sep 30;131(8):654-669. doi: 10.1161/CIRCRESAHA.121.320449. Epub 2022 Sep 16.
Cardiovascular outcomes among giant cell myocarditis compared with cardiac sarcoidosis: A propensity score-matched analysis.
Jaiswal V, Hanif M, Mashkoor Y, Sawhney A, Kumar T, Yasmeen J, Sundas FNU, Mattumpuram J, Hajra A, Lavie CJ, Bandyopadhyay D.
Prog Cardiovasc Dis. 2025 Mar-Apr;89:63-68. doi: 10.1016/j.pcad.2024.11.002. Epub 2024 Nov 16.
Inflammatory Cardiomyopathic Syndromes.
Trachtenberg BH, Hare JM.
Circ Res. 2017 Sep 15;121(7):803-818. doi: 10.1161/CIRCRESAHA.117.310221.
Myocarditis.
Blauwet LA, Cooper LT.
Prog Cardiovasc Dis. 2010 Jan-Feb;52(4):274-88. doi: 10.1016/j.pcad.2009.11.006.
Treating Myocardial Inflammation in Cardiac Sarcoidosis: Why, With What, and for How Long?
Blankstein R, Divakaran S.
JACC Cardiovasc Imaging. 2022 Nov;15(11):1956-1959. doi: 10.1016/j.jcmg.2022.07.016. Epub 2022 Oct 19.
Cardiac magnetic resonance in giant cell myocarditis: a matched comparison with cardiac sarcoidosis.
Pöyhönen P, Nordenswan HK, Lehtonen J, Syväranta S, Shenoy C, Kupari M.
Eur Heart J Cardiovasc Imaging. 2023 Mar 21;24(4):404-412. doi: 10.1093/ehjci/jeac265.
